CrossrefInfokarte
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
Blood and Lymphatic Cancer: Targets and Therapy · 2017
DOI: 10.2147/blctt.s105458 ↗Abstract
Kein Abstract verfügbar.
EUVIMED